Chen K W, Kumar R, Williams B T. "一种阿可替尼杂质12的合成方法" [P]. US Patent, US 9368264 B2, 2015-06-17.
发明人陈志强,何建平,罗永刚. "Method for the Synthesis of Acalabrutinib Impurity 12" [P]. 中国发明专利, 专利号 CN 115272682 B, 授权公告日 2021-06-22.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 阿可替尼杂质12 in Pharmaceutical Formulations". J. Agric. Food Chem., 2018, 633, (9), 45-54.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿可替尼杂质12 as an Impurity". Anal. Chim. Acta, 2023, 2011, 5049-5056.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Acalabrutinib Impurity 12 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2024, 1965, 4419-4443.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate 阿可替尼杂质12 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2012, 2458, (3), 5598-5608.